SCHEMBL28686141

SCHEMBL28686141

C(=C/c1n[nH]c2ccc(Cc3ccccc3)cc12)\c1ccccn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 10/20 0.58
NTRK2 Q16620 9/20 0.58
NTRK3 Q16288 8/20 0.58
CHEK1 O14757 1/20 0.52
KDR P35968 6/20 0.45
AURKA O14965 4/20 0.44
AURKB Q96GD4 3/20 0.44
FGFR1 P11362 4/20 0.44
CSF1R P07333 3/20 0.44
PDGFRB P09619 3/20 0.44
KIT P10721 3/20 0.44
PDGFRA P16234 3/20 0.44
LCK P06239 3/20 0.44
PLK4 O00444 2/20 0.44
MAP4K4 O95819 2/20 0.44
PAK4 O96013 2/20 0.44
ABL1 P00519 2/20 0.44
RET P07949 2/20 0.44
MET P08581 2/20 0.44
FLT1 P17948 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28686143 1.00 NTRK1 (0.58) NTRK1NTRK2NTRK3CHEK1KDR
SCHEMBL28684857 0.92 NTRK1 (0.64) NTRK1NTRK2NTRK3CHEK1KDR
SCHEMBL28684861 0.92 NTRK1 (0.64) NTRK1NTRK2NTRK3CHEK1KDR
SCHEMBL29387722 0.91 NTRK1 (0.54) NTRK1NTRK2NTRK3CHEK1KDR
SCHEMBL28698706 0.91 NTRK1 (0.54) NTRK1NTRK2NTRK3CHEK1KDR
SCHEMBL28698708 0.91 NTRK1 (0.54) NTRK1NTRK2NTRK3CHEK1KDR
SCHEMBL29387760 0.90 NTRK1 (0.64) NTRK1NTRK2NTRK3CHEK1KDR
SCHEMBL28706600 0.90 NTRK1 (0.53) NTRK1NTRK2NTRK3CHEK1KDR
SCHEMBL28684921 0.89 NTRK1 (0.55) NTRK1NTRK2NTRK3CHEK1KDR
SCHEMBL28684924 0.89 NTRK1 (0.55) NTRK1NTRK2NTRK3CHEK1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4056558-A1 INDAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION OF SAME, AND APPLICATIONS THEREOF Jinan University (CN) 2022-09-14 EP disclosed
US-20220281821-A1 INDAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS JINAN UNIVERSITY (CN) 2022-09-08 US disclosed
CN-114072387-A Indazole compound and medicinal composition and application thereof 暨南大学 2022-02-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220281821-A1 INDAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS TNK2, TNNI3K, CSNK1G3 NTRK1 63/4885NTRK2 162/4885NTRK3 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.